Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

Protein Expression and Purification

Volumn 51, Issue 2, 2007, Pages 276-282

  Lin, Zhihua ^a   Lei, Huanzong ^a   Cao, Peng ^b  

^a LISHUI UNIVERSITY   (China)

^b Jiangsu Province Institute of Traditional Chinese Medicine   (China)

Author keywords

CD spectra; Fluorescence spectra; Inclusion bodies; Protein expression; Protein purification; Refolding; sTRAIL

Indexed keywords

RECOMBINANT PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; CELL INCLUSION; CHEMISTRY; CIRCULAR DICHROISM; DRUG EFFECT; ESCHERICHIA COLI; HELA CELL; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; PROTEIN FOLDING; PROTEIN RENATURATION; SPECTROFLUOROMETRY;

AMINO ACID SEQUENCE; CIRCULAR DICHROISM; ESCHERICHIA COLI; HELA CELLS; HUMANS; INCLUSION BODIES; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PROTEIN FOLDING; PROTEIN RENATURATION; RECOMBINANT PROTEINS; SPECTROMETRY, FLUORESCENCE; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

ESCHERICHIA COLI;

EID: 33751404538     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.07.026     Document Type: Article

References (20)

1. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., and Smith C.A. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673-682
2. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A., and Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271 (1996) 12687-12690
3. Griffith T.S., and Lynch D.H. TRAIL: a molecule with multiple receptors and control mechanisms. Curr. Opin. Immunol. 10 (1998) 559-563
4. Walczak H., Miller R.E., Ariail K., Gliniak B., Griffith T.S., Kubin M., Chin W., Jones J., Woodward A., Le T., Smith C., Smolak P., Goodwin R.G., Rauch C.T., Schuh J.C., and Lynch D.H. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5 (1999) 157-163
5. Cha S.S., Kim M.S., Choi Y.H., Sung B.J., Shin N.K., Shin H.C., Sung Y.C., and Oh B.H. 2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity 11 (1999) 253-261
6. Hymowitz S.G., Christinger H.W., Fuh G., Ultsch M., O'Connell M., Kelley R.F., Ashkenazi A., and de Vos A.M. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor. Mol. Cell 4 (1999) 563-571
7. Rogl H., Kosemund K., Kuhlbrandt W., and Collinson I. Refolding of Escherichia coli produced membrane protein inclusion bodies immobilised by nickel chelating chromatography. FEBS Lett. 432 (1998) 21-26
8. Dutta S., Lalitha P.V., Ware L.A., Barbosa A., Moch J.K., Vassell M.A., Fileta B.B., Kitov S., Kolodny N., Heppner D.G., Haynes J.D., and Lanar D.E. Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli. Infect. Immun. 70 (2002) 3101-3110
9. Marti T. Refolding of bacteriorhodopsin from expressed polypeptide fragments. J. Biol. Chem. 273 (1998) 9312-9322
10. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 277 (1970) 680-685
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
12. Markossian K.A., and Kurganov B.I. Protein folding, misfolding, and aggregation. Formation of inclusion bodies and aggresomes. Biochemistry (Mosc) 69 (2004) 971-984
13. Cabrita L.D., and Bottomley S.P. Protein expression and refolding-a practical guide to getting the most out of inclusion bodies. Biotechnol. Annu. Rev. 10 (2004) 31-50
14. Li M., Su Z.G., and Janson J.C. In vitro protein refolding by chromatographic procedures. Protein Expr. Purif. 33 (2004) 1-10
15. Tsumoto K., Ejima D., Kumagai I., and Arakawa T. Practical considerations in refolding proteins from inclusion bodies. Protein Expr. Purif. 28 (2003) 1-8
16. Bushmarina N.A., Blanchet C.E., Vernier G., and Forge V. Cofactor effects on the protein folding reaction: acceleration of alpha-lactalbumin refolding by metal ions. Protein Sci. 15 (2006) 659-671
17. Eck M.J., and Sprang S.R. The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J. Biol. Chem. 264 (1989) 17595-17605
18. Eck M.J., Ultsch M., Rinderknecht E., de Vos A.M., and Sprang S.R. The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution. J. Biol. Chem. 267 (1992) 2119-2122
19. Hymowitz S.G., O'Connell M.P., Ultsch M.H., Hurst A., Totpal K., Ashkenazi A., de Vos A.M., and Kelley R.F. A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry 39 (2000) 633-640
20. Nam G.H., and Choi K.Y. Association of human tumor necrosis factor-related apoptosis-inducing ligand with membrane upon acidification. Eur. J. Biochem. 269 (2002) 5280-5287